Home Advanced Accelerator Applications

Advanced Accelerator Applications

acquired
IPO
Developer of Targeted Radioligand Therapy and Precision Radioligand Imaging Agents
Basic
Enterprise Profile

Basic Information

Advanced Accelerator Applications develops, manufactures, and commercializes drugs for targeted radioligand therapy and precision radioligand imaging. Our expertise is built on a tradition of over 15 years in the manufacturing and commercialization of a portfolio of PET and SPECT nuclear medicine imaging products, which are applicable to many indications in oncology, neurology, cardiology, as well as infectious and inflammatory diseases.
Advanced Accelerator Applications S.A.
Auvergne-Lon-Alpes,France
101~500 people
January 01, 2002
pharmacovigilance@adacap.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Gene Technology Biotechnology
Concept
Support Departments Disease Treatment Tumor Infectious Diseases Mental Disorders # Nervous System Diseases
Application Scenarios
Chemical Drug Innovative Drugs